Upstream Bio, Inc. (UPB)
7.18
+0.57
(+8.62%)
USD |
NASDAQ |
Aug 25, 16:00
7.18
0.00 (0.00%)
After-Hours: 18:08
Upstream Bio Price : 7.18 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 7.00 | 7.11 | 6.46 | 6.61 | 538545.0 |
| Aug 21, 2026 | 6.91 | 7.006 | 6.85 | 6.97 | 434242.0 |
| Aug 20, 2026 | 7.48 | 7.555 | 6.745 | 6.85 | 592939.0 |
| Aug 19, 2026 | 7.04 | 7.53 | 6.91 | 7.515 | 574179.0 |
| Aug 18, 2026 | 7.28 | 7.435 | 6.73 | 6.85 | 461780.0 |
| Aug 17, 2026 | 7.02 | 7.19 | 6.86 | 7.14 | 852441.0 |
| Aug 14, 2026 | 6.95 | 7.14 | 6.80 | 7.07 | 688249.0 |
| Aug 13, 2026 | 7.02 | 7.04 | 6.87 | 6.91 | 378835.0 |
| Aug 12, 2026 | 7.00 | 7.25 | 6.84 | 6.91 | 635221.0 |
| Aug 11, 2026 | 7.48 | 7.70 | 7.01 | 7.09 | 628056.0 |
| Aug 10, 2026 | 7.32 | 7.62 | 7.20 | 7.44 | 869591.0 |
| Aug 07, 2026 | 6.94 | 7.26 | 6.89 | 7.25 | 621846.0 |
| Aug 06, 2026 | 6.75 | 7.166 | 6.66 | 6.87 | 427172.0 |
| Aug 05, 2026 | 6.77 | 6.88 | 6.58 | 6.74 | 917312.0 |
| Aug 04, 2026 | 6.40 | 6.915 | 6.40 | 6.79 | 1.362M |
| Aug 03, 2026 | 6.31 | 6.43 | 6.175 | 6.42 | 774290.0 |
| Jul 31, 2026 | 6.58 | 6.688 | 6.29 | 6.31 | 297715.0 |
| Jul 30, 2026 | 6.35 | 6.665 | 6.29 | 6.57 | 320723.0 |
| Jul 29, 2026 | 6.39 | 6.48 | 6.21 | 6.41 | 702778.0 |
| Jul 28, 2026 | 6.40 | 6.54 | 6.09 | 6.40 | 433233.0 |
| Jul 27, 2026 | 6.47 | 6.60 | 6.26 | 6.40 | 459477.0 |
| Jul 24, 2026 | 6.40 | 6.61 | 6.16 | 6.41 | 626431.0 |
| Jul 23, 2026 | 6.46 | 6.59 | 6.32 | 6.40 | 626146.0 |
| Jul 22, 2026 | 6.95 | 6.99 | 6.47 | 6.59 | 704553.0 |
| Jul 21, 2026 | 6.92 | 7.08 | 6.86 | 6.98 | 340980.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sutro Biopharma, Inc. | 21.39 |
| Compass Therapeutics, Inc. | 2.52 |
| ACADIA Pharmaceuticals, Inc. | 30.58 |
| Alnylam Pharmaceuticals, Inc. | 239.95 |
| Anika Therapeutics, Inc. | 21.52 |
Price Related Metrics
| PS Ratio | 123.38 |
| PEG Ratio | -0.0610 |
| Price to Book Value | 1.451 |
| Earnings Yield | -40.20% |
| Market Cap | 393.26M |
| PEGY Ratio | -0.0610 |